Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations.

Fibroblast growth factor 23 (FGF-23) is known to be produced by the bone and linked to metabolic risk. We aimed to explore circulating FGF-23 in association with fatness and insulin sensitivity, atherosclerosis and bone mineral density (BMD). Circulating intact FGF-23 (iFGF-23) and C-terminal (CtFGF...

Full description

Bibliographic Details
Main Authors: José Manuel Fernández-Real, Josep Puig, Marta Serrano, Mónica Sabater, Antoni Rubió, José María Moreno-Navarrete, Marina Fontan, Roser Casamitjana, Gemma Xifra, Francisco José Ortega, Javier Salvador, Gema Frühbeck, Wifredo Ricart
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3605441?pdf=render